Tag: Sonova

Sonova Releases 2021/21 Annual Report

Sonova says that “a sharp dip in activity in April 2020 was followed by a swift recovery, reflecting the market’s strong fundamentals, the successful launch of the Phonak Paradise platform, and Sonova’s strategic growth initiatives.” All three businesses returned to growth in the second half of the financial year, with sales up 6.6% in local currencies.

Read More

Sonova to Acquire Sennheiser Consumer Division

Sonova Holding AG announced that it has signed an agreement to acquire the Consumer Division from Sennheiser electronic GmbH & Co KG (Sennheiser). The Sennheiser Consumer Division, which concentrates on the business of headphones and hearables for private customers, is said to be “an excellent fit with Sonova’s strategy to lead innovation in hearing experience and to engage consumers early on their hearing journey.”

Read More

Sonova to Acquire 3.7% Ownership Stake in Sensorion

Sensorion, a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that Sonova Holding AG will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million (USD $6.08 million).

Read More

Sonova Announces Expected ‘Return to Growth’ in Second Half of 2020/21

Sonova now expects sales for the first half of FY 2020/21 to reach around 79% of the prior year level at constant exchange rates and to achieve an adjusted EBITA margin in Swiss francs of approximately 15% for the same period. For the second half of the financial year, the Group expects to return to growth, achieving a revenue increase of 4%-8% and a rise in the adjusted EBITA in the range of 20%-30% compared with the prior year period, both at constant exchange rates.

Read More